Omicron Updated: Key Questions Answered .

As Omicron rapidly emerged as the dominant SARS-CoV-2 variant, early evidence raised urgent questions about transmissibility, vaccine protection, and public health response. Preliminary data suggest Omicron spreads more readily than Delta—even among vaccinated individuals—and reduces vaccine-induced neutralization. However, booster doses appear to restore significant protection against symptomatic infection and hospitalization. Observational and laboratory studies also indicate that vaccines still confer substantial defense against severe disease. This report explores the implications for vaccine strategy, public health planning, and the global path forward.